Migdal Insurance & Financial Holdings’s Novo Nordisk NVO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Hold	2,780	–	–	﹤0.01%	236
2026 Q1	$102K	Hold	2,780	–	–	﹤0.01%	242
2025 Q4	$141K	Hold	2,780	–	–	﹤0.01%	225
2025 Q3	$154K	Hold	2,780	–	–	﹤0.01%	221
2025 Q2	$192K	Sell	2,780 -340,609	-99%	-$23.2M	﹤0.01%	212
2025 Q1	$24.2M	Buy	343,389 +339,820	+9,521%	+$28.1M	0.34%	52
2024 Q4	$307K	Sell	3,569 -1,800	-34%	-$195K	﹤0.01%	192
2024 Q3	$640K	Sell	5,369 -2,709	-34%	-$361K	0.01%	165
2024 Q2	$1.16M	Sell	8,078 -183	-2%	-$24.3K	0.02%	146
2024 Q1	$1.06M	Sell	8,261 -185	-2%	-$22K	0.02%	143
2023 Q4	$874K	Buy	8,446 +1,300	+18%	+$129K	0.02%	174
2023 Q3	$651K	Buy	+7,146	New	+$629K	0.01%	176

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Migdal Insurance & Financial Holdings's NVO Position: Q2 2026 in Review

Migdal Insurance & Financial Holdings held its Novo Nordisk (NVO) position steady in Q2 2026 at 2,780 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

Migdal Insurance & Financial Holdings first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $24.2M in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Migdal Insurance & Financial Holdings held 2,780 shares of Novo Nordisk worth $133K as of Q2 2026.
Migdal Insurance & Financial Holdings left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of Migdal Insurance & Financial Holdings's portfolio in Q2 2026, its #236 holding.
Migdal Insurance & Financial Holdings first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
Migdal Insurance & Financial Holdings's Novo Nordisk position peaked at $24.2M in Q1 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2026, filed 10 Aug 2026.